Crispr Therapeutics shares owned by Charles Schwab Investment Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Charles Schwab Investment Management
from 13F filings
Historical chart of Charles Schwab Investment Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Charles Schwab Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $34M | 724k | 46.98 |
| 2024-06-30 | $39M | 718k | 54.01 |
| 2024-03-31 | $46M | 669k | 68.16 |
| 2023-12-31 | $41M | 653k | 62.60 |
| 2023-09-30 | $29M | 638k | 45.39 |
| 2023-06-30 | $36M | 647k | 56.14 |
| 2023-03-31 | $29M | 641k | 45.23 |
| 2022-12-31 | $26M | 641k | 40.65 |
| 2022-09-30 | $41M | 622k | 65.35 |
| 2022-06-30 | $21M | 348k | 60.77 |
| 2022-03-31 | $22M | 355k | 62.77 |
More positions owned by Charles Schwab Investment Management
Home Depot (HD)
View all positions for Charles Schwab Investment Management